Riskpilot← Back to searchSign inGet full accessSG Medical AB
ABActiveOrg 5591981591Hammarby Allé 105General medical practice activities · NACE 8621Est. 20191 employees
Revenue 2025
SEK 165K
+365% vs 2024
EBITDA margin
72.6%
+240% vs 2024
Equity ratio
80.0%
Financial strength
Net profit 2025
SEK 110K
+229% vs 2024
| Revenue | SEK 165K | +365% |
| EBITDA | SEK 120K | +240% |
| Net profit | SEK 110K | +229% |
| Total assets | SEK 271K | +106% |
| Equity | SEK 217K | +103% |
| Employees | 1 | — |
Legal name
SG Medical AB
Org number
5591981591
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 mars 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkartjänster, konsultverksamhet inom hälsovård, utbildning och undervisning samt författande av läromedel inom hälsa och medicin, handel med läkemedel, livsmedel och hälsokost. Äga och förvalta fast och lös egendom, handel med aktier och andra värdepapper. Även import av alkoholhaltiga drycker samt därmed förenlig verksamhet.
Address
Hammarby Allé 105
Email
sgkiortzi@yahoo.gr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 173 | 452 | 307 | 35 | 165 |
| Staff expenses | — | −371 | 38 | −68 | −0 |
| EBITDA | 18 | −101 | 198 | −85 | 120 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 18 | −101 | 198 | −85 | 120 |
| Net financials | −1 | −1 | 0 | 0 | 0 |
| Profit before tax | 17 | −29 | 199 | −85 | 120 |
| Tax | −4 | — | −40 | — | −10 |
| Net profit | 13 | −29 | 158 | −85 | 110 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 372 | 103 | 282 | 132 | 271 |
| Equity | 222 | 34 | 192 | 107 | 217 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 77 | 69 | 90 | 25 | 54 |
| Total debt | 77 | 69 | 90 | 25 | 54 |
EBITDA margin
72.6%
This company
15.8%
Market median
+359% vs market
20212025
Equity ratio
80.0%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
50.6%
This company
18.4%
Market median
+175% vs market
20212025
Net profit margin
66.8%
This company
8.1%
Market median
+725% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SG Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dimitrios Gkiortzis | Deputy Board Member | 0 companies |
| Sofia Gkiortzi | Board of Directors | 0 companies |